{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:51:15Z","timestamp":1775739075619,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00464-022-09294-8","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T19:03:16Z","timestamp":1651258996000},"page":"8503-8508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of adhesions in patients using liraglutide before laparoscopic sleeve gastrectomy"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-0301","authenticated-orcid":false,"given":"Mumin","family":"Hakim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abdulraziq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al Shehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"9294_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA (2017) Mechanisms, pathophysiology, and management of obesity. N Engl J Med 376:254\u2013266","journal-title":"N Engl J Med"},{"key":"9294_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1467-789X.2007.00393.x","volume":"8","author":"AS Poobalan","year":"2007","unstructured":"Poobalan AS, Aucott LS, Smith WC et al (2007) Long-term weight loss effects on all-cause mortality in overweight\/obese populations. Obes Rev 8:503\u2013513","journal-title":"Obes Rev"},{"key":"9294_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/1359105312451865","volume":"18","author":"F Wright","year":"2013","unstructured":"Wright F, Boyle S, Baxter K et al (2013) Understanding the relationship between weight loss, emotional well-being and health-related quality of life in patients attending a specialist obesity weight management service. J Health Psychol 18:574\u2013586","journal-title":"J Health Psychol"},{"key":"9294_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2646","volume":"348","author":"SU Dombrowski","year":"2014","unstructured":"Dombrowski SU, Knittle K, Avenell A et al (2014) Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. BMJ 348:g2646","journal-title":"BMJ"},{"issue":"1 Suppl","key":"9294_CR5","doi-asserted-by":"publisher","first-page":"222s","DOI":"10.1093\/ajcn\/82.1.222S","volume":"82","author":"RR Wing","year":"2005","unstructured":"Wing RR, Phelan S (2005) Long-term weight loss maintenance. Am J Clin Nutr 82(1 Suppl):222s-s225","journal-title":"Am J Clin Nutr"},{"key":"9294_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/oby.20394","volume":"21","author":"GA Bray","year":"2013","unstructured":"Bray GA (2013) Why do we need drugs to treat the patient with obesity? Obesity (Silver Spring) 21:893\u2013899","journal-title":"Obesity (Silver Spring)"},{"key":"9294_CR7","doi-asserted-by":"publisher","first-page":"323rv2","DOI":"10.1126\/scitranslmed.aad1811","volume":"8","author":"AR Saltiel","year":"2016","unstructured":"Saltiel AR (2016) New therapeutic approaches for the treatment of obesity. Sci Transl Med 8:323rv2","journal-title":"Sci Transl Med"},{"key":"9294_CR8","unstructured":"(2021) Liraglutide. Novo Nordisk Inc., Plainsboro, NJ. https:\/\/www.novo-pi.com\/saxenda.pdf. Accessed 15 Dec 2021"},{"key":"9294_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0343-6","author":"LV Jacobsen","year":"2015","unstructured":"Jacobsen LV, Flint A, Olsen AK et al (2015) Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetic and pharmacodynamics. Clin Pharmacokinet. https:\/\/doi.org\/10.1007\/s40262-015-0343-6","journal-title":"Clin Pharmacokinet"},{"key":"9294_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40265-015-0408-8","volume":"75","author":"LJ Scott","year":"2015","unstructured":"Scott LJ (2015) Liraglutide: a review of its use in the management of obesity. Drugs 75:899\u2013910. https:\/\/doi.org\/10.1007\/s40265-015-0408-8","journal-title":"Drugs"},{"key":"9294_CR11","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.2165\/11208110-000000000-00000","volume":"71","author":"CM Perry","year":"2011","unstructured":"Perry CM (2011) Liraglutide: a review of its use in the management of type 2 diabetes mellitus. Drugs 71:2547\u20132573. https:\/\/doi.org\/10.2165\/11208110-000000000-00000","journal-title":"Drugs"},{"key":"9294_CR12","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s40265-014-0321-6","volume":"74","author":"LJ Scott","year":"2014","unstructured":"Scott LJ (2014) Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus. Drugs 74:2161\u20132174. https:\/\/doi.org\/10.1007\/s40265-014-0321-6","journal-title":"Drugs"},{"key":"9294_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 373:11\u201322","journal-title":"N Engl J Med"},{"key":"9294_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ijo.2013.120","volume":"37","author":"TA Wadden","year":"2013","unstructured":"Wadden TA, Hollander P, Klein S et al (2013) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study. Int J Obes (Lond) 37:1443\u20131451","journal-title":"Int J Obes (Lond)"},{"key":"9294_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diabres.2012.02.016","volume":"97","author":"M Horowitz","year":"2012","unstructured":"Horowitz M, Flint A, Jones KL et al (2012) Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. Diabetes Res Clin Pract 97:258\u2013266. https:\/\/doi.org\/10.1016\/j.diabres.2012.02.016","journal-title":"Diabetes Res Clin Pract"},{"key":"9294_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ijo.2013.162","volume":"38","author":"J Van Can","year":"2014","unstructured":"Van Can J, Sloth B, Jensen CB et al (2014) Effects of the once daily GLP-1 analogue liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes 38:784","journal-title":"Int J Obes"},{"key":"9294_CR17","unstructured":"US Food and Drug Administration. Guidance for industry developing products for weight management. http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm071612.pdf. Accessed 1 Jan 2022"},{"issue":"7","key":"9294_CR18","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2337\/db09-0058","volume":"58","author":"AV Matveyenko","year":"2009","unstructured":"Matveyenko AV, Dry S, Cox HI et al (2009) Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes 58(7):1604\u20131615","journal-title":"Diabetes"},{"issue":"1","key":"9294_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00125-009-1515-4","volume":"53","author":"JS Nachnani","year":"2010","unstructured":"Nachnani JS, Bulchandani DG, Nookala A et al (2010) Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia 53(1):153\u2013159","journal-title":"Diabetologia"},{"issue":"2","key":"9294_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2337\/dc09-1499","volume":"33","author":"DJ Drucker","year":"2010","unstructured":"Drucker DJ, Sherman SI, Gorelick FS, Bergenstal RM, Sherwin RS, Buse JB (2010) Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care 33(2):428\u2013433","journal-title":"Diabetes Care"},{"issue":"7","key":"9294_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamainternmed.2013.2720","volume":"173","author":"S Singh","year":"2013","unstructured":"Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB (2013) Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med 173(7):534\u2013539","journal-title":"JAMA Intern Med"},{"issue":"5","key":"9294_CR22","doi-asserted-by":"publisher","first-page":"e00380","DOI":"10.14309\/crj.0000000000000380","volume":"7","author":"RD Dolan","year":"2020","unstructured":"Dolan RD, Bazarbashi AN, Lo A, Smith BN (2020) Liraglutide-induced hemorrhagic pancreatitis in a nondiabetic patient. ACG Case Rep J 7(5):e00380. https:\/\/doi.org\/10.14309\/crj.0000000000000380","journal-title":"ACG Case Rep J"},{"issue":"7","key":"9294_CR23","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2337\/dc16-2747","volume":"40","author":"WM Steinberg","year":"2017","unstructured":"Steinberg WM, Buse JB, Ghorbani MLM, Orsted DD, Nauck MA (2017) Amylase, lipase, and acute pancreatitis in people with type 2 diabetes treated with liraglutide: results from the LEADER randomized trial. Diabetes Care 40(7):966\u2013972","journal-title":"Diabetes Care"},{"issue":"7","key":"9294_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2337\/dc16-2684","volume":"40","author":"WM Steinberg","year":"2017","unstructured":"Steinberg WM, Rosenstock J, Wadden TA, Donsmark M, Jensen CB, DeVries JH (2017) Impact of liraglutide on amylase, lipase, and acute pancreatitis in participants with overweight\/obesity and normoglycemia, prediabetes, or type 2 diabetes: secondary analyses of pooled data from the SCALE clinical development program. Diabetes Care 40(7):839\u2013848","journal-title":"Diabetes Care"},{"issue":"10","key":"9294_CR25","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2016.1531","volume":"176","author":"JL Faillie","year":"2016","unstructured":"Faillie JL, Yu OH, Yin H, Hillaire-Buys D, Barkun A, Azoulay L (2016) Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus. JAMA Intern Med 176(10):1474\u20131481","journal-title":"JAMA Intern Med"},{"issue":"1","key":"9294_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF01536153","volume":"34","author":"S Willemer","year":"1989","unstructured":"Willemer S, Adler G (1989) Histochemical and ultrastructural characteristics of tubular complexes in human acute pancreatitis. Dig Dis Sci 34(1):46\u201355","journal-title":"Dig Dis Sci"},{"issue":"7","key":"9294_CR27","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.2337\/db12-1686","volume":"62","author":"AE Butler","year":"2013","unstructured":"Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC (2013) Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 62(7):2595\u20132604","journal-title":"Diabetes"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09294-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-022-09294-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09294-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T15:31:43Z","timestamp":1666884703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-022-09294-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["9294"],"URL":"https:\/\/doi.org\/10.1007\/s00464-022-09294-8","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mumin Hakim, Mohammed Fathi, Mohammed Abdulraziq, and Mohammed Al Shehri have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}